Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

A novel once-daily fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer's disease: two phase I studies in healthy volunteers.

Boinpally R, Chen L, Zukin SR, McClure N, Hofbauer RK, Periclou A.

Clin Drug Investig. 2015 Jul;35(7):427-35. doi: 10.1007/s40261-015-0296-4.

2.

Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer's dementia: a pooled area under the curve analysis.

Atri A, Hendrix SB, Pejović V, Hofbauer RK, Edwards J, Molinuevo JL, Graham SM.

Alzheimers Res Ther. 2015 May 18;7(1):28. doi: 10.1186/s13195-015-0109-2. eCollection 2015.

3.

A review of β-amyloid neuroimaging in Alzheimer's disease.

Adlard PA, Tran BA, Finkelstein DI, Desmond PM, Johnston LA, Bush AI, Egan GF.

Front Neurosci. 2014 Oct 31;8:327. doi: 10.3389/fnins.2014.00327. eCollection 2014. Review.

4.
5.

Beneficial effect of antibodies against β- secretase cleavage site of APP on Alzheimer's-like pathology in triple-transgenic mice.

Rabinovich-Nikitin I, Rakover IS, Becker M, Solomon B.

PLoS One. 2012;7(10):e46650. doi: 10.1371/journal.pone.0046650. Epub 2012 Oct 10.

6.

Behavioral disturbances in dementia.

Müller-Spahn F.

Dialogues Clin Neurosci. 2003 Mar;5(1):49-59.

7.

Mapping the structural brain changes in Alzheimer's disease: the independent contribution of two imaging modalities.

Canu E, McLaren DG, Fitzgerald ME, Bendlin BB, Zoccatelli G, Alessandrini F, Pizzini FB, Ricciardi GK, Beltramello A, Johnson SC, Frisoni GB.

J Alzheimers Dis. 2011;26 Suppl 3:263-74. doi: 10.3233/JAD-2011-0040.

8.

Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states.

Miller Y, Ma B, Nussinov R.

Proc Natl Acad Sci U S A. 2010 May 25;107(21):9490-5. doi: 10.1073/pnas.0913114107. Epub 2010 May 6.

9.

Microstructural diffusion changes are independent of macrostructural volume loss in moderate to severe Alzheimer's disease.

Canu E, McLaren DG, Fitzgerald ME, Bendlin BB, Zoccatelli G, Alessandrini F, Pizzini FB, Ricciardi GK, Beltramello A, Johnson SC, Frisoni GB.

J Alzheimers Dis. 2010;19(3):963-76. doi: 10.3233/JAD-2010-1295.

10.

Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice.

Martinez-Coria H, Green KN, Billings LM, Kitazawa M, Albrecht M, Rammes G, Parsons CG, Gupta S, Banerjee P, LaFerla FM.

Am J Pathol. 2010 Feb;176(2):870-80. doi: 10.2353/ajpath.2010.090452. Epub 2009 Dec 30.

11.
12.

Linkage and association studies identify a novel locus for Alzheimer disease at 7q36 in a Dutch population-based sample.

Rademakers R, Cruts M, Sleegers K, Dermaut B, Theuns J, Aulchenko Y, Weckx S, De Pooter T, Van den Broeck M, Corsmit E, De Rijk P, Del-Favero J, van Swieten J, van Duijn CM, Van Broeckhoven C.

Am J Hum Genet. 2005 Oct;77(4):643-52. Epub 2005 Aug 30.

13.

In what extent anemia coexists with cognitive impairment in elderly: a cross-sectional study in Greece.

Argyriadou S, Vlachonikolis I, Melisopoulou H, Katachanakis K, Lionis C.

BMC Fam Pract. 2001;2:5. Epub 2001 Oct 25.

Supplemental Content

Support Center